How melanoma and other tumors succeed in hiding and resisting immunotherapy
Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...
Precision Medicine Online13h
FDA Expands Pluvicto Indication to Earlier Line of Treatment for PSMA-Positive Prostate Cancer
NEW YORK – The US Food and Drug Administration on Friday expanded the indication for Novartis' radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for use prior to chemotherapy in ...
Immatics N.V.: Trading Below Cash, But Not Without Reason
Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...
Royal family’s timeline of health woes as Charles battles cancer treatment side effects
King Charles has returned to Clarence House after a brief hospital stay. His hospitalisation was sparked by side effects from ...